Whistleblowers are essential to reporting Covid-19 fraud. They can play an important role in making sure that the trillions of dollars of government funding for coronavirus pandemic relief allocated under the CARES Act and other government programs are being spent and directed appropriately.
Whistleblower attorneys Phillips & Cohen have the experience and track record to help those who are trying to figure out how to report coronavirus-related fraud and corruption.
Before stepping forward, whistleblowers should consider their options and how best to protect themselves by consulting with experienced and successful whistleblower attorneys.
Whenever the government spends massive amounts of money – as it is doing in the coronavirus crisis – fraud is likely. Whistleblowers can help stop fraud involving coronavirus relief funds authorized by the CARES Act, as well as fraud that takes advantage of investors, states, government agencies and other entities during this Covid-19 pandemic.
In many instances, whistleblowers who report coronavirus frauds may qualify for protection from job retaliation and also receive a reward.
In cases where the fraud involves government funds, the False Claims Act could apply. That law protects whistleblowers from employment retaliation and provides rewards of 15 percent to 30 percent when the government recovers funds in the whistleblower case. Whistleblowers work with whistleblower attorneys to file lawsuits, known as “qui tam” cases, to get the government to investigate.
Those who blow the whistle on securities law violations related to the coronavirus pandemic can do so confidentially through the Securities and Exchange Commission whistleblower program, which also offers whistleblowers protection from job retaliation and rewards.
[Want to talk to an experienced whistleblower attorney about your case? Contact Phillips & Cohen for a free, confidential review.]
CARES Act fraud and fraud involving other Covid-19-related relief funds – info for whistleblowers
The government is spending trillions of dollars under the CARES Act, the Paycheck Protection Program and the Health Care Enhancement Act and other programs to help big businesses, small businesses, universities and other entities.
It’s important that those desperately needed funds are properly spent and that the entities that receive the Covid-19 relief funds are truly eligible. Entities that receive funds must comply with government terms and conditions, and applications for coronavirus funds must be accurate.
The government has limited resources to determine whether the recipients of the emergency loans and grants are truly eligible for the funds and whether the funds are properly spent. Whistleblower are needed to provide insider information about Covid-19-related fraud that the government otherwise would never discover.
Whistleblowers who know of fraud cases involving government and state coronavirus funds may be eligible for rewards under the False Claim Act. Here are some examples of the types of fraud that might qualify as False Claims Act cases:
- Providing false information in an application for pandemic funds, such as for the Small Business Administration loans under the Small Business Paycheck Protection Program.
- Receiving government funds for which the business or entity is not entitled.
- Using coronavirus assistance for improper purposes that aren’t allowed under the CARES Act or violate the terms and conditions of the government funding. For instance, certain coronavirus relief funds for healthcare providers may be used only to prevent, prepare for and respond to Covid-19 or to reimburse for lost revenues attributable to the coronavirus incurred on or after Jan. 3, 2020.
- Providing substandard or defective equipment – including personal protective equipment – pharmaceutical drugs or services to the government or any healthcare provider or other entity that uses government funds for those purchases or services.
- Falsifying test results from research funded by the FDA to get FDA approval for vaccines and other treatments for Covid-19.
- Paying kickbacks to get government contracts related to the coronavirus crisis.
- Charging unjustifiably higher prices for government procurement orders than for similar orders by non-governmental entities.
- Failing to comply with the Buy American Act and the Trade Agreements Act.
Covid-19 and healthcare fraud – whistleblowers needed
Healthcare fraud is always a problem, and now many fraud schemes are taking advantage of the chaos and fears of the coronavirus pandemic.
Whistleblowers and their attorneys are critical to tackling healthcare fraud related to the coronavirus crisis and to protecting Medicare, Medicaid and other government funds that so many depend on for their healthcare and survival. They can stop the fraud by using the False Claims Act to file qui tam lawsuits.
Some examples of coronavirus healthcare fraud schemes that could be the basis for a qui tam case:
- Off-label marketing of pharmaceutical drugs or medical devices for Covid-19-related uses the FDA has not approved.
- Kickbacks paid to get referrals for healthcare services or medical supplies in violation of the Anti-Kickback Statute.
- Offering free Covid-19 tests tied to unnecessary medical tests or treatments that the provider bills to Medicare, Medicaid or other government healthcare program.
- Fraudulent telemedicine or telehealth bills, such as billing Medicare or Medicaid for medically unnecessary services or services that weren’t provided.
- Billing government healthcare programs for fraudulent Covid-19 treatments and preventative measures.
- Upcoding to take advantage of higher fees for treating Covid-19 patients on Medicare.
[Questions or concerns about being a whistleblower? Contact Phillips & Cohen for a free, confidential consultation.]
SEC whistleblowers and Covid-19 fraud and corruption
The SEC is spending significant time and resources on enforcement related to coronavirus fraud, but it needs the help of whistleblowers – particularly insiders who can provide detailed information about significant Covid-19-related financial misconduct.
Under the SEC whistleblower program, whistleblowers can confidentially report their information about Covid-19 fraud and corruption to the SEC. The law protects SEC whistleblowers from job retaliation and offers rewards ranging from 10 percent to 30 percent of the sanctions collected as a result of the information and assistance provided by the whistleblower and the whistleblower’s attorney.
Some of the types of Covid-19-related fraud and corruption the SEC expects to see include:
- Microcap fraud. Microcap stocks are particularly vulnerable to fraudulent investment schemes, including those related to the coronavirus crisis.
- Fraudulent statements about a company’s business regarding Covid-19-related matters.
- Market manipulation.
- Insider trading.
- False disclosures in financial statements.
- Bribes of foreign officials disguised as charitable donations and other violations of the Foreign Corrupt Practices Act.
- Financial disclosures or valuations that may attempt to hide previously undisclosed problems or weaknesses as coronavirus-related.
- Improper marketing and sale of complex structured products to retail investors.
- Failures to honor redemption requests at private funds or registered investment companies, which might indicate an underlying issue.
Whistleblower attorneys Phillips & Cohen LLP: 32 years of success
Phillips & Cohen is the nation’s most successful law firm representing whistleblowers, with more than $12.8 billion recovered as a result of its cases. The firm’s whistleblower attorneys have won more than $1.1 billion in rewards for its clients. Phillips & Cohen represents whistleblowers in qui tam lawsuits (False Claims Act cases) as well as cases brought under the whistleblower programs of the SEC, the Commodity Futures Trading Commission and the Internal Revenue Service. www.phillipsandcohen.com